Interfacial interaction between benzo[a]pyrene and pulmonary surfactant: Adverse effects on lung health

Inhaled polycyclic aromatic hydrocarbons (PAHs) can directly interact with the lung surfactant (PS) lining of alveoli, thereby affecting the normal physiological functions of PS, which is a serious threat to lung health. In spite of the extensive study of benzo[a]pyrene (BaP, a representative of PAHs), its potential biophysical influence on the natural PS is still largely unknown. In this study, the interfacial interaction between PS (extracted from porcine lungs) and BaP is investigated in vitro. The results showed that the surface tension, phase behavior, and interfacial structure of the PS monolayers were obviously altered in the presence of BaP. A solubilization test manifested that PS and its major components (dipalmitoyl phosphatidylcholine, DPPC; bovine serum albumin, BSA) could in turn accelerate the dissolution of BaP, which followed the order: PS > DPPC > BSA, and mixed phospholipids were significantly responsible for the solubilization of BaP by PS. In addition, solubilization of BaP also enhanced the consumption of hydroxyl radicals (·OH) in the simulated lung fluid, which could disturb the balance between oxidation and antioxidation.